← SynDRA
ARTEMETHER
SynDRA canonical compound SYN0020186 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | ATP1A1 | CYP2B6 | CYP2C19 | CYP3A5 |
|---|
| Mechanism of action | antimalarial agent |
|---|
| Indication | malaria |
|---|
| Disease area | infectious disease |
|---|
All known targets
- ATP1A1
- CYP2B6
- CYP2C19
- CYP3A5
Mechanisms of action (all sources)
- antimalarial agent
- ATP1A1 BINDER
Drug classes
- Antimalarial
- Anti-Infective Agents
- Antimalarials
- Antiparasitic Agents
- Antiprotozoal Agents
ATC classes
Cross-references
Synonyms
- artemos
- artenam
- artesaph
- dihydroartemisinin methyl ether
- falcidol
- gvither
- malartem
- beta-Artemether
- Artemetero
- .beta.-artemether
- Artemetherum
- Artesaph
- Falcidol
- Gvither
- Larither
- Malartem
- Paluther
- NSC-665970
- NSC-759820
- SM 224
- SM224
- Artemether component of coartem
- Artemetheri
- Dihydroartemisinin impurity g
- Artemether[inn]
- Artemos
- Artenam
- Artesian
- Artimist
- Artmether
- Rither
- Arteannuin ether
- Artemether [INN]
- Artemisininelactol methyl ether
- Dihydroartemisinin methyl ether
- Dihydroquinghaosu methyl ether
- SM-224
- SM 229
Reported adverse events
- Abdominal pain
- Arthralgia
- Aspartate aminotransferase increased
- Asthenia
- Chills
- Cough
- Dizziness
- Fatigue
- Headache
- Hepatomegaly
- Hypersensitivity
- Infection
Look up ARTEMETHER in the interactive SynDRA portal →